Patents by Inventor Nader Abutaleb

Nader Abutaleb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240066022
    Abstract: The present application generally relates to a method to treat a patient with a bacterial infection caused by Clostridium difficile. Particularly the method compromises the step of administering a therapeutically effective amount of diiodohydroxyquinoline, with or without one or more anti-infective agents, to the patient in need of relief from said infection. Methods of uses and composition matters are within the scope of this disclosure.
    Type: Application
    Filed: November 6, 2023
    Publication date: February 29, 2024
    Applicant: Purdue Research Foundation
    Inventors: Mohamed Seleem, Nader Abutaleb
  • Patent number: 11806342
    Abstract: A method to treat a patient with a Clostridium difficile infection comprising administering a therapeutically effective amount of diiodohydroxyquinoline, with or without one or more anti-infective agents.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: November 7, 2023
    Assignee: Purdue Research Foundation
    Inventors: Mohamed Seleem, Nader Abutaleb
  • Publication number: 20210100787
    Abstract: The present application generally relates to a method to treat a patient with a bacterial infection caused by Clostridium difficile. Particularly the method compromises the step of administering a therapeutically effective amount of diiodohydroxyquinoline, with or without one or more anti-infective agents, to the patient in need of relief from said infection. Methods of uses and composition matters are within the scope of this disclosure.
    Type: Application
    Filed: October 6, 2020
    Publication date: April 8, 2021
    Applicant: Purdue Research Foundation
    Inventors: Mohamed Seleem, Nader Abutaleb